Robin J. Mishler

Array ( [id] => 6148642 [patent_doc_number] => 20110020237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Compositions and Methods for Inhibiting Drusen Formation and for Diagnosing or Treating Drusen-Related Disorders' [patent_app_type] => utility [patent_app_number] => 11/795373 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13340 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020237.pdf [firstpage_image] =>[orig_patent_app_number] => 11795373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219322 [patent_doc_number] => 20070160633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Methods for enhancing therapeutic effects of a neurotoxin' [patent_app_type] => utility [patent_app_number] => 11/330893 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15283 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160633.pdf [firstpage_image] =>[orig_patent_app_number] => 11330893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5624884 [patent_doc_number] => 20060263389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Methods and compositions to enhance immune responses via recall antigens' [patent_app_type] => utility [patent_app_number] => 11/326869 [patent_app_country] => US [patent_app_date] => 2006-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19277 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263389.pdf [firstpage_image] =>[orig_patent_app_number] => 11326869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5857953 [patent_doc_number] => 20060228371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Immunological control of beta-amyloid levels in vivo' [patent_app_type] => utility [patent_app_number] => 11/324500 [patent_app_country] => US [patent_app_date] => 2006-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16587 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228371.pdf [firstpage_image] =>[orig_patent_app_number] => 11324500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196113 [patent_doc_number] => 07638119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Method of diminishing the symptoms of neurodegenerative disease' [patent_app_type] => utility [patent_app_number] => 11/290293 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8159 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638119.pdf [firstpage_image] =>[orig_patent_app_number] => 11290293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5595754 [patent_doc_number] => 20060159670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors' [patent_app_type] => utility [patent_app_number] => 11/289150 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12977 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159670.pdf [firstpage_image] =>[orig_patent_app_number] => 11289150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028420 [patent_doc_number] => 20070269867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells' [patent_app_type] => utility [patent_app_number] => 11/283005 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8844 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269867.pdf [firstpage_image] =>[orig_patent_app_number] => 11283005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693652 [patent_doc_number] => 20060153799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders' [patent_app_type] => utility [patent_app_number] => 11/267820 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16182 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153799.pdf [firstpage_image] =>[orig_patent_app_number] => 11267820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649690 [patent_doc_number] => 20060135425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke' [patent_app_type] => utility [patent_app_number] => 11/264088 [patent_app_country] => US [patent_app_date] => 2005-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 15855 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135425.pdf [firstpage_image] =>[orig_patent_app_number] => 11264088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7772975 [patent_doc_number] => 08119127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Cytokine antagonists for neurological and neuropsychiatric disorders' [patent_app_type] => utility [patent_app_number] => 11/262528 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7448 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119127.pdf [firstpage_image] =>[orig_patent_app_number] => 11262528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5888579 [patent_doc_number] => 20060275744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Modified human embryonic stem cells and methods of use to treat neuron-associated disorders' [patent_app_type] => utility [patent_app_number] => 11/258359 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 25295 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275744.pdf [firstpage_image] =>[orig_patent_app_number] => 11258359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 356163 [patent_doc_number] => 07488599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-10 [patent_title] => 'Methods for culturing mammalian taste cells' [patent_app_type] => utility [patent_app_number] => 11/249854 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11835 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/488/07488599.pdf [firstpage_image] =>[orig_patent_app_number] => 11249854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820447 [patent_doc_number] => 20060024760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Human brain carboxypeptidase B' [patent_app_type] => utility [patent_app_number] => 11/233958 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15781 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024760.pdf [firstpage_image] =>[orig_patent_app_number] => 11233958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821258 [patent_doc_number] => 20060025571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Morphogen-induced dendritic growth' [patent_app_type] => utility [patent_app_number] => 11/226555 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 32730 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025571.pdf [firstpage_image] =>[orig_patent_app_number] => 11226555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655195 [patent_doc_number] => 20060140930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Promotion of central nervous system remyelination using monoclonal autoantibodies' [patent_app_type] => utility [patent_app_number] => 11/224664 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15854 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140930.pdf [firstpage_image] =>[orig_patent_app_number] => 11224664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5595710 [patent_doc_number] => 20060159626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Method for administering a cytokine to the central nervous system and the lymphatic system' [patent_app_type] => utility [patent_app_number] => 11/222669 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26566 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159626.pdf [firstpage_image] =>[orig_patent_app_number] => 11222669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279177 [patent_doc_number] => 20090131309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'ICA512 COUPLES INSULIN SECRETION AND GENE EXPRESSION IN BETA-CELLS' [patent_app_type] => utility [patent_app_number] => 11/574568 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 32119 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131309.pdf [firstpage_image] =>[orig_patent_app_number] => 11574568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5770680 [patent_doc_number] => 20050266504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Methods for diagnosing and treating Alzheimers disease and Parkinson\'s disease' [patent_app_type] => utility [patent_app_number] => 11/147022 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18988 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266504.pdf [firstpage_image] =>[orig_patent_app_number] => 11147022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677748 [patent_doc_number] => 20060183104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Cellular models of neuron-associated disorders and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/196376 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 16165 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183104.pdf [firstpage_image] =>[orig_patent_app_number] => 11196376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434949 [patent_doc_number] => 20090169535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'TREATMENT OF EPILEPSY BY EXPRESSING ST3GAL-III' [patent_app_type] => utility [patent_app_number] => 11/658830 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13281 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169535.pdf [firstpage_image] =>[orig_patent_app_number] => 11658830 [rel_patent_id] =>[rel_patent_doc_number] =>)